
|Articles|June 2, 2003
Sluggish antibiotic pipeline driving 'superbug' fears
Severe acute respiratory syndrome (SARS) has garnered a lot of media attention over the past several months, but a lingering and more insidious health problem is getting far less press than SARS. According to infectious disease experts, the public health threat posed by antibiotic-resistant bacteria is a healthcare crisis that requires immediate attention.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Navigating Compounding Peptides and GLP-1s Through Regulations
2
Understanding the Restructure of US Pharmacy Benefits Amid Reform, Regulatory Action
3
The 2026 GLP-1 Compounding Crackdown: A Pharmacist’s Guide
4
Pharmacist Involvement Speeds Prior Authorization for GLP-1s
5


























